Pharma China (www.pharmachinaonline.com) is the most influential English media and source of business intelligence covering the Chinese pharmaceutical sector. Pharma China caters for the growing needs of the international pharmaceutical industry for up-to-date and insightful information and intelligence on China’s burgeoning but increasingly complex healthcare marketplace, and is subscribed by most MNC pharma companies, leading CROs, investment banks, consulting firms active in China as well as relevant industry associations and government agencies.

Note: To view full text of free articles, you need to register as a basic member first and then log in. To view premium articles, you need to subscribe to Pharma China as a premium member. For more information or subscription, please contact info@pharmachinaonline.com. If you wish to unsubscribe from this e-Alert, please reply this e-mail with "Remove" in the subject line.
Editor´s Picks
Shanghai Regulator: Speaking Fees to Physicians Constitute Bribery(8/14/2018 )  (Premium)
SCMP: Fierce Competition in China's Nascent Immuno-therapy Cancer Drugs Market Could Compromise Safety(8/14/2018 )  (Premium)
China National Drug Administration Sets Guidelines for Overseas Drug Trial Data(8/14/2018 )  (Premium)
Big Pharma Opportunities Aplenty in China(8/14/2018 )  (Premium)
The Market
SMEI: Chinese Drug Terminal Market Up 6.9% in H1(8/13/2018 )  (Premium)
Industry News
Adlai Nortye Opens R&D Site in Boston(8/17/2018 )  (free)
China Grand Given More Time for Acquisition Offer to Sinclair Pharma(8/16/2018 )  (Premium)
CNDA Approves Hengrui¡¯s Breast Cancer Drug Pyrotinib Conditionally(8/16/2018 )  (Premium)
Kintor and Frontier Reportedly Seeking IPOs in Hong Kong(8/16/2018 )  (Premium)
Chinese Pharma Growth Continues to Slow as Shares of Online Pharmacies and CHCs Go Up(8/16/2018 )  (Premium)
Chinese Online Drugstore 111 Inc. Files For $200M US IPO(8/15/2018 )  (Premium)
Blackstone Invests $400M in YiChang HEC Change(8/15/2018 )  (Premium)
IQVIA: Peeking Into China's Healthcare Deals(8/14/2018 )  (Premium)
EU: Zhejiang Tianyu the Second Chinese Producer of Tainted Heart Drug(8/14/2018 )  (Premium)
India's Pharmexcil to sign MoU with China Trade Body for Expedite Drug Approvals(8/14/2018 )  (Premium)
Haisco and Pneuma Enter Equity Investment and China Distribution Deal(8/13/2018 )  (Premium)
Regulatory News
CDE Solicits Comments of Draft Guidelines for Aluminum Adjuvant in Preventative Vaccines(8/17/2018 )  (Premium)
Chinese Pharmacopoeia Commission Announces Proposed Addition of 40 Biologics in ChP 2020(8/14/2018 )  (Premium)
General Health
NHC and SATCM Issue Notice for Building of Tiered Medical Service System(8/14/2018 )  (Premium)
State Council Issues Notice to Divide Fiscal Responsibilities of Central and Local Governments for Healthcare(8/14/2018 )  (Premium)
Legal/IPR News
Trump Lashes Out on China and Mexico for Opioid and Fentanyl "Warfare"(8/16/2018 )  (Premium)
Gilead's Key Sovaldi Patent Claims Partially Invalidated in China(8/16/2018 )  (Premium)
Product/R&D News
CANbridge Approved to Commence CAN017 Ib/III Trial for ESCC in China(8/14/2018 )  (free)
Sihuan Pharma's Self-Developed Anticancer Pirotinib Commenced Phase II Trial in China(8/14/2018 )  (free)
API/Bulk Drug News
Indian Drugmakers Hit by Rising Prices of Chinese Intermediates(8/16/2018 )  (Premium)
FDA Warns Four Manufacturers from China, India and Canada(8/14/2018 )  (Premium)
People in the News
Recent Executive Moves(8/17/2018 )  (Premium)
Top Drug Regulators and Senior Local Officials Punished over Vaccine Scandal(8/16/2018 )  (Premium)
© Wicon International Group¡¡Support by: www.heightow.com Home | Site map | Contact Us | Links